Grimes & Company’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $315K | Buy |
708
+2
| +0.3% | +$890 | 0.01% | 330 |
|
|
2025
Q1 | $342K | Buy |
706
+57
| +9% | +$27.6K | 0.01% | 279 |
|
|
2024
Q4 | $261K | Buy |
649
+19
| +3% | +$7.65K | 0.01% | 328 |
|
|
2024
Q3 | $293K | Buy |
630
+1
| +0.2% | +$465 | 0.01% | 293 |
|
|
2024
Q2 | $295K | Buy |
629
+22
| +4% | +$10.3K | 0.01% | 273 |
|
|
2024
Q1 | $254K | Buy |
607
+98
| +19% | +$41K | 0.01% | 290 |
|
|
2023
Q4 | $207K | Buy |
+509
| New | +$207K | 0.01% | 301 |
|
|
2022
Q2 | – | Sell |
-911
| Closed | -$238K | – | 301 |
|
|
2022
Q1 | $238K | Buy |
+911
| New | +$238K | 0.01% | 265 |
|